Bleeding Clinical Trials in Boston, Massachusetts
9 recruitingBoston, Massachusetts
Showing 1–9 of 9 trials
Recruiting
Not Applicable
Delivering tAN to Reduce HMB: The LUNA Study
Heavy Menstrual Bleeding
Spark Biomedical, Inc.80 enrolled1 locationNCT07326722
Recruiting
Phase 3
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
Atrial FibrillationStrokeBleeding
Icahn School of Medicine at Mount Sinai3,200 enrolled101 locationsNCT04045665
Recruiting
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
ThrombophiliaThrombosisSickle Cell Disease+10 more
American Thrombosis and Hemostasis Network3,000 enrolled71 locationsNCT04398628
Recruiting
Phase 3
Study of OCTAPLEX in Patients With Acute Major Bleeding on DOAC Therapy With Factor Xa Inhibitor
Acute Major Bleeding
Octapharma260 enrolled63 locationsNCT04867837
Recruiting
Not Applicable
Randomized Trial of UI-EWD vs. Conventional Endoscopic Therapy for Nonvariceal Upper Gastrointestinal Bleeding
Acute Gastrointestinal Bleeding
Medtronic - MITG278 enrolled15 locationsNCT06188585
Recruiting
Not Applicable
Marginal Ulcer Healing With Low-Thermal Argon Plasma Endoscopic Treatment
Gastrointestinal BleedingDysphagiaVomiting+9 more
Christopher C. Thompson, MD, MSc100 enrolled1 locationNCT06543316
Recruiting
Comprehensive HHT Outcomes Registry of the United States (CHORUS)
Gastrointestinal BleedingTelangiectasiaArteriovenous Malformations+4 more
Cure HHT10,000 enrolled16 locationsNCT06259292
Recruiting
Post Marketing Observational Study on Safety of BALFAXAR vs. KCENTRA for Reversal of Vitamin K Antagonist Induced Anticoagulation in Adults Undergoing Urgent Surgery or Invasive Procedure
Vitamin K-Dependent Coagulation DefectSignificant Bleeding Risk
Octapharma3,574 enrolled1 locationNCT06429787
Recruiting
The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia
BleedingNeonatal Thrombocytopenia
Karolinska Institutet250 enrolled8 locationsNCT04598750